A pilot study of IL-1 inhibition by anakinra in acute gout, Arthritis Research & Therapy, vol.9, issue.2, p.28, 2007. ,
DOI : 10.1186/ar2143
The inflammatory process of gout and its treatment, Arthritis Research & Therapy, vol.8, 2006. ,
Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, vol.20, issue.7081, pp.237-241, 2006. ,
DOI : 10.1038/nature04516
Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra, Arthritis Care & Research, vol.64, issue.Suppl, pp.1381-1384, 2013. ,
DOI : 10.1002/acr.21989
Successful treatment of resistant pseudogout with anakinra, Arthritis & Rheumatism, vol.66, issue.2, pp.631-633, 2008. ,
DOI : 10.1002/art.23119
Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis, Joint Bone Spine, vol.79, issue.6, pp.621-623, 2012. ,
DOI : 10.1016/j.jbspin.2012.01.010
Efficacy of anakinra in articular chondrocalcinosis: Report of three cases, Joint Bone Spine, vol.79, issue.3, pp.330-331, 2012. ,
DOI : 10.1016/j.jbspin.2011.12.017
Preliminary criteria for the classification of the acute arthritis of primary gout, Arthritis & Rheumatism, vol.20, issue.3, pp.895-900, 1977. ,
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Beh??et's disease, Autoimmunity Reviews, vol.14, issue.1, pp.1-9, 2015. ,
DOI : 10.1016/j.autrev.2014.08.008
Safety issues and concerns of new immunomodulators in rheumatology, Expert Opinion on Drug Safety, vol.21, issue.7, pp.389-399, 2015. ,
DOI : 10.1136/annrheumdis-2014-205246
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure, Joint Bone Spine, vol.76, issue.4, pp.424-426, 2009. ,
DOI : 10.1016/j.jbspin.2009.01.001
IL1 blockade in crystal-induced arthritis: Impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. ???Efficacy of anakinra in articular chondrocalcinosis???, Joint Bone Spine, vol.80, issue.1, pp.115-116, 2013. ,
DOI : 10.1016/j.jbspin.2012.09.002
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1?? Secretion through the NLRP3 Inflammasome In Vitro, The Journal of Immunology, vol.186, issue.4, pp.2495-2502, 2011. ,
DOI : 10.4049/jimmunol.1001284
Monosodium urate, hydroxyapatite, and calcium pyrophosphate crystals induce tumor necrosis factor-í µí»¼ expression in a mononuclear cell line, The Journal of Rheumatology, vol.24, issue.12, pp.2385-2388, 1997. ,
Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives, Mediators of Inflammation, vol.62, issue.1, 2015. ,
DOI : 10.1016/j.jbspin.2013.12.011
Hydroxyapatite pseudopodagra. A syndrome of young women, Arthritis & Rheumatism, vol.29, issue.6, pp.741-747, 1989. ,
DOI : 10.1002/anr.1780320612
Bridging the Gap between the Clinician and the Patient with Cryopyrin-Associated Periodic Syndromes, International Journal of Immunopathology and Pharmacology, vol.360, issue.4, pp.827-836, 2011. ,
DOI : 10.1097/bor.0000174210.78449.6b
Untangling the Web of Systemic Autoinflammatory Diseases, Mediators of Inflammation, vol.29, issue.6, 2014. ,
DOI : 10.1097/BRS.0b013e3181c09601